Frontiers in Cancer Biotechnology Research

Explore groundbreaking studies, clinical trial updates, and emerging technologies shaping the future of cancer treatment.

Research Articles

OX401: How a PARP Agonist Could Revolutionize Cancer Immunotherapy

Explore Onxeo's OX401, a novel PARP agonist with dual anti-tumor and immunological properties that could transform cancer treatment approaches.

Chloe Mitchell
Oct 07, 2025

Popular Articles